CHARLES & COLVARD LTD (CTHR)

US1597651066 - Common Stock

0.3481  -0.01 (-2.22%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CTHR. CTHR was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CTHR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CTHR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

CTHR had negative earnings in the past year.
In the past year CTHR has reported a negative cash flow from operations.
In multiple years CTHR reported negative net income over the last 5 years.
Of the past 5 years CTHR 4 years had a positive operating cash flow.

1.2 Ratios

CTHR has a worse Return On Assets (-51.85%) than 90.00% of its industry peers.
The Return On Equity of CTHR (-66.85%) is worse than 82.00% of its industry peers.
Industry RankSector Rank
ROA -51.85%
ROE -66.85%
ROIC N/A
ROA(3y)-5.63%
ROA(5y)-5.01%
ROE(3y)-7.42%
ROE(5y)-6.44%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CTHR (31.27%) is worse than 78.00% of its industry peers.
In the last couple of years the Gross Margin of CTHR has declined.
CTHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.91%
GM growth 5Y-3.46%

6

2. Health

2.1 Basic Checks

CTHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CTHR has less shares outstanding
The number of shares outstanding for CTHR has been increased compared to 5 years ago.
There is no outstanding debt for CTHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CTHR has an Altman-Z score of -0.73. This is a bad value and indicates that CTHR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.73, CTHR is not doing good in the industry: 84.00% of the companies in the same industry are doing better.
CTHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.73
ROIC/WACCN/A
WACC9.27%

2.3 Liquidity

A Current Ratio of 2.84 indicates that CTHR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.84, CTHR is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
CTHR has a Quick Ratio of 1.65. This is a normal value and indicates that CTHR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.65, CTHR is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 1.65

1

3. Growth

3.1 Past

CTHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1400.00%.
Looking at the last year, CTHR shows a very negative growth in Revenue. The Revenue has decreased by -31.90% in the last year.
CTHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.07% yearly.
EPS 1Y (TTM)-1400%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-200%
Revenue 1Y (TTM)-31.9%
Revenue growth 3Y0.86%
Revenue growth 5Y2.07%
Revenue growth Q2Q-23.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y90.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTHR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTHR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CTHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHARLES & COLVARD LTD

NASDAQ:CTHR (5/2/2024, 2:16:17 PM)

0.3481

-0.01 (-2.22%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.56M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.85%
ROE -66.85%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 31.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.84
Quick Ratio 1.65
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1400%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y90.44%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-31.9%
Revenue growth 3Y0.86%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y